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Introduction 
Despite advances in medical interventions, infective endo-
carditis (IE) remains a disease entity with considerable mor-
bidity and mortality.1-4) Poor prognoses of IE are related to val-
vular regurgitation and abscess formation secondary to tissue 
destruction, heart failure, and embolic complications.5) Risk 
factors of IE in industrialized countries are intravenous drug 
use, degenerative valve disease, intracardiac devices, health 
care-associated infection, and hemodialysis.4)6) Most cases of IE 
seemed to develop in patients with underlying structural heart 
disease. However, IE rarely involves the valves without predis-
posing abnormalities. 
In Korea, Park et al.7) reported two cases about Streptococcus 
agalactias (S. agalactiae) IE with diabetes in 2006. In 2009, Lim 
et al.8) reported about the case of an S. agalactiae IE patient 
who also had advanced gastric cancer. On the contrary, we rep-
resent the case of a young, immunocompetent and non-preg-
nant woman patient who had structurally normal heart. There 
were major embolic event as the complication of S. agalactiae 
IE. Without any surgery, she made a complete neurological 
recovery after catheter directed thrombolysis. And The vege-
tation was disappeared after antimicrobial treatment without 
surgery.
Case
A 26-year-old woman who was previously healthy and had 
no history of chronic diseases was presented with sudden onset 
of mental change. Meticulous history taking revealed her his-
tory of dental scaling 6 weeks ago and intermittent fever for 
last 2 weeks. The patient did not have any obstetric and gyne-
cologic problem such as recent abortion, and urine human 
chorionic gonadotropin (hCG) test was negative. When she 
had been transferred to our emergency department she showed 
confused mental status and fever of 38.5°C. The blood pres-
sure was 110/70 mmHg and the pulse rate was 96 per min-
ute. Grade III/VI systolic murmur was audible at the apical 
area. Physical examination revealed left eyeball deviation, 
complete gaze palsy with right hemiparesis (grade III/V), and 
global aphasia. Electrocardiogram showed sinus tachycardia. 
It was suspected that she had suffered from cerebroembolic 
events caused by IE. Emergent cerebral angiography was per-
formed for the evaluation of suspected acute cerebral embo-
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lism. There was embolic obstruction at the distal portion of 
left internal carotid artery (ICA) (Fig. 1A). Catheter directed 
infusion by 200,000 unit of the urokinase was performed. Fi-
nal angiography showed successful recanalization of ICA and 
middle cerebral artery (MCA) (Fig. 1B). Brain magnetic reso-
nance imaging showed findings of acute infarction in left MCA 
territory and focal hemorrhage in left lentiform nucleus (Fig. 
1C). Transthoracic echocardiography revealed a 0.8 × 0.5 cm-
sized, highly mobile echogenic material on the posterior mi-
tral valve (MV) leaflet suggesting vegetation (Fig. 2A). Three 
pairs of blood cultures were positive for S. agalactiae on admis-
sion. On the second day of antibiotic therapy, the bacterial 
cultures became negative. The patient was administered intra-
venous ceftriaxone for 4 weeks during the hospitalization. Fol-
low-up echocardiography was performed on the seventh day 
of antibiotic therapy. It showed disappearance of the vegeta-
tion (Fig. 2B). There were no structurally abnormalities on 
MV (Fig. 2C). Only trivial mitral regurgitation was present 
after antibiotic therapy. She showed complete neurological re-
covery and got discharged. 
Discussion
IE features persistent bacteremia resulting from typical or-
ganisms for IE and evidence of cardiac valvular involvement 
(e.g. vegetation, new murmur of valvular regurgitation, para-
valvular abscess).6) The incidence of IE is approximately 1.7-
6.2 cases per year for every 100,000 patients. Despite advances 
in medical interventions, IE remains a disease with consider-
able morbidity and mortality.1-4)
In 2007, American Heart Association (AHA) revised the 
guidelines for IE prophylaxis to more clearly define when IE 
prophylaxis is recommended. They concluded that prophylaxis 
is reasonable only for patients with underlying cardiac condi-
tions, for every dental procedures.9) IE has been well known for 
its occurrence in patients with underlying cardiac problems 
(e.g. rheumatic valvulopathies, congenital cyanotic heart dis-
eases). However in recent other predisposing factors emerged, 
such as intravenous drug use, degenerative valve diseases, intra-
cardiac devices, healthcare-associated infection, and hemodialy-
sis. IE is now affecting patients without previously known 
valve diseases as the result of healthcare-associated procedures. 
The mainstay of therapy of IE remains prompt antibiotic 
therapy. Surgery is indicated in specific patients of IE with 
congestive heart failure, perivalvular invasive diseases, fungal 
IE or uncontrolled infection despite maximal antimicrobial 
therapy.6)9)
Up to 65 percent of embolic events in IE involve the central 
nervous system, and neurologic complications develop in 20 
Fig. 1. Cerebral angiography shows complete thrombotic obstruction at the distal portion of left ICA (A). Final angiography after percutaneous thrombolysis 
shows good patency of left MCA, ACA and ICA (B). Brain MRI shows acute infarction in left MCA territory (circle) and focal hemorrhage in left lentiform 
nucleus (arrow) (C). ICA: internal carotid artery, MCA: middle cerebral artery, ACA: anterior cerebral artery, MRI: magnetic resonance imaging.
Fig. 2. Transthoracic echocardiography shows 0.8 × 0.5 cm-sized, echogenic and hypermobile mass on PMVL (A). Follow-up after antimicrobial 
therapy, echogenic mass was disappeared compared with previous study (B). Transthoracic echocardiography shows structurally normal MV during 
the end-systolic phase (C). PMVL: posterior mitral valve leaflet, MV: mitral valve.
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to 40 percent of all patients of IE.5-7) The use of thrombolytic 
therapy in patients with IE suffering from embolic events is 
controversial. Whether the increased risk of intracranial hem-
orrhage in patients with IE is to be considered a contraindica-
tion for thrombolysis is unclear.
Traditionally S. agalactiae was an unusual pathogen in adults 
who are not pregnant.10) The incidence of invasive S. agalactiae 
infection was recently increasing in both elderly people and 
those with comorbid conditions.10) 
In 2010, Ivanova Georgieva et al.11) underwent a cohort study 
about 27 IE patients due to S. agalactiae and reported that S. 
agalactiae IE often develops in patients who have underlying 
diseases such as diabetes mellitus, liver cirrhosis, malignancy, 
and abnormalities in immune responses. They suggested that 
S. agalactiae IE progress aggressively resulting in high mortali-
ty. Thus an urgent valve surgery should be performed where 
necessary such as the disease accompanies complications.11)12) 
In our case, interestingly, the patient was a nonpregnant, im-
munocompetent and young woman who had no definite cardi-
ac problems. Nevertheless, IE resulted in major stroke a life-
threatening complication.  
Decision making regarding the role of medical therapy or 
surgical intervention is complex and must be individualized to 
the patient. And it affects improvement of the prognosis in IE 
patients. In our case, we diagnosed IE with major stroke in ear-
ly phase with echocardiography. And the patient was complete 
recovered neurologically by percutaneous intervention and 
prompt antimicrobial therapy without valve surgery.    
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